Uncategorized – cronan.co.uk

Unwired Planet – AIPPI Rapid Response Seminar – Part 2

On 13 November 2018 AIPPI held a rapid response seminar on the SEP Litigation and FRAND licensing decision of the Court of Appeal in Huawei v Unwired Planet [2018] EWCA Civ 2344.

This is Part Two of this article. Please see here for Part One.

Part Two looks at the responses to the Judgment and its wider consequences. We kick off again with Richard Vary and Sir Robin Jacob.

The Consequences of the Judgment

Whether the FRAND obligation extends to an obligation to license to all parties is currently a hot topic.

Does the Unwired Planet Judgment indicate that FRAND undertakings oblige licensors to licence to other parties at all parts of the supply chain?… Read more...

Unwired Planet – AIPPI Rapid Response Seminar – Part 1

On 13 November 2018 AIPPI held a rapid response seminar on the decision of the Court of Appeal in Huawei v Unwired Planet [2018] EWCA Civ 2344. What follows is a write up of the event – the first part is an analysis of the issues in the case and the arguments on appeal – the second part contains further insight from the hosts into the Judgment and its effect on global SEP and FRAND litigation more generally.

(Part Two is available here).

The evening was hosted by The Rt. Hon. Prof. Sir Richard Jacob (UCL) and Richard Vary of Bird & Bird (formerly of Nokia), in response to the handing down by the Court of Appeal of its much-awaited Judgment in the Huawei v Unwired Planet Standard Essential Patent (SEP) Litigation, in relation to 2G/GSM,3G/UMTS and 4G/LTE technologies used in mobile phones. … Read more...

What’s wrong with the Supreme Court’s Pregabalin decision?

Everything to do with second medical use patents.

Not because of any fault in the legal reasoning: because the decision came to be made by a Court at all.

If you haven’t yet had a chance to read the Pregabalin Judgment then you can save yourself some time by reading this excellent summary by Darren Smyth of EIP.

This article isn’t going to re-tread any ground. It’s about whether the law relating to second medical use patents is fit for purpose, and whether a Court should really be making these assessments, Supreme or not.

The reason you should care about patenting new uses for existing drugs, even if you’re not a patent lawyer, is because it is the future of healthcare.… Read more...

Contender, ready?

Gladiator, ready?

So spoke John Anderson in the classic 1990s TV show Gladiator. What’s that got to do with IP law? The answer can be found in the case of KBF Enterprises v Gladiator Nutrition [2018] EWHC 3041 (IPEC), handed down by Recorder Amanda Michaels on 9 November 2018.

The case is one of trade mark infringement and passing off. As you’ll remember, one of the eponymical Gladiators was named Warrior, and was played by a man called Daniel Singh – the Third Defendant.

The Claimant, KBF, also known by its trading name of BodyBuilding Warehouse, own marks including WARRIOR SUPPLEMENTS and WARRIOR in classes 5, 30 and 32, covering goods such as protein supplements and vitamins.… Read more...

Hello world

I’ve owned cronan.co.uk for more than ten years now. I always promised myself I would get around to producing an elegant and simple homepage in HTML and CSS: a true testament to my IT credentials.

I think it is safe to say that day was never going to come.

Rationally, my time is much better spent focusing on my actual job than learning additional tangential skills in some kind of meta-display of technical ability. Maybe one day I’ll finish that MOOC and finally get to grips with HTML 5 on Codeacademy. All things being equal I think I’d rather leave it to the professionals.… Read more...